Caitong International Asset Management’s Oscar Health OSCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$446K Buy
15,630
+14,139
+948% +$304K 0.06% 250
2026
Q1
$17.1K Buy
1,491
+89
+6% +$1.25K ﹤0.01% 1015
2025
Q4
$20.1K Sell
1,402
-3,176
-69% -$54.9K ﹤0.01% 981
2025
Q3
$86.7K Sell
4,578
-12,153
-73% -$200K 0.06% 195
2025
Q2
$359K Buy
16,731
+13,288
+386% +$198K 0.26% 46
2025
Q1
$45.1K Buy
3,443
+2,854
+485% +$42.4K 0.03% 526
2024
Q4
$7.92K Buy
+589
New +$9.48K 0.01% 990

Other funds holding OSCR

Caitong International Asset Management's OSCR Position: Q2 2026 in Review

Caitong International Asset Management increased its Oscar Health (OSCR) stake by 948% in Q2 2026, buying an estimated $304K and bringing the position to 15,630 shares worth $446K. The position accounts for 0.06% of the portfolio, ranked #250.

Caitong International Asset Management first reported a position in OSCR in Q4 2024 and has held it in 7 quarters since. 404 funds tracked by Wall St. Rank hold OSCR as of Q2 2026.

  • Caitong International Asset Management held 15,630 shares of Oscar Health worth $446K as of Q2 2026.
  • Caitong International Asset Management bought 14,139 Oscar Health shares in Q2 2026, an estimated $304K.
  • Oscar Health made up 0.06% of Caitong International Asset Management's portfolio in Q2 2026, its #250 holding.
  • Caitong International Asset Management first reported a position in Oscar Health in Q4 2024 and has held it in 7 quarters since.
  • 404 funds tracked by Wall St. Rank held Oscar Health as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.